Wykładowcy
Barry Drees was a witness to the start of the genetech revolution when he got his PhD in molecular genetics at the University of California at San Francisco in the 1980’s. Following his postdoctoral work as a fellow of the National Institute of Health, he worked as a medical writer in the pharmaceutical industry at Hoechst/Aventis for 12 years, setting up a Phase I writing group and leading several regulatory submission teams. Barry is a frequent speaker on medical writing, statistics and other scientific communication topics for Management Forum and the European Medical Writers Association (EMWA) as well as various pharmaceutical associations. He also speaks on non-scientific topics such as introductory presentations on the history of Malta and the city of Frankfurt at the 20th and 29th EMWA conferences. He has appeared on an educational television programme in Germany to discuss the ethics of genetic engineering and radio to discuss medical writing as a career. He is the former Editor-in-chief of “The Write Stuff”, the Journal of EMWA, and is currently a Senior Partner of Trilogy Writing & Consulting. He has served on the EMWA Professional Development Committee (EPDC) since 2006, with a focus on Train-the-Trainer events.
Liz Wager is a freelance medical writer, editor, and trainer. Before setting up her own company, Sideview (in 2001), she worked for Janssen Cilag, GlaxoWellcome, and Blackwell Scientific Publications. She chairs COPE (the Committee on Publication Ethics) and is a member of the ethics committees of the BMJ and WAME (the World Association of Medical Editors). She helped develop the Good Publication Practice guidelines for pharmaceutical companies, the EMWA guidelines for medical writers, Wiley-Blackwell’s Best Practice on Publication Ethics, COPE’s Best Practice for journal editors, the WHO standards for trial registration, and CONSORT for abstracts. She has run workshops on writing, publication strategy and publication ethics for doctors, writers and editors on five continents. She is the author of books on publication strategy and peer review (Getting Research Published: an A to Z of Publication Strategy, Radcliffe Publishing 2005 – second edition due March 2010; How to Survive Peer Review, BMJ Books 2001) and has published many papers and book chapters. She acts as a peer reviewer for BMJ, JAMA, Journal of Medical Ethics, Learned Publishing, Medical Journal of Australia, and PLoS Medicine, and is a Visiting Fellow of the UK Cochrane Centre.
Dr Carpenter has a PhD in Pharmacology and spent 18 years as Lecturer in Pharmacology in the Faculty of Medicine at the University of Manchester in the UK. Since leaving academia Dr Carpenter has been a medical writer and medical communications specialist, now working as a freelance consultant. In this role he has worked with all the major global pharmaceutical companies in a wide range of therapeutic areas, developing and writing, for example, educational material, papers for publication in peer-reviewed journals, reviews, newsletters, and slide presentations for symposia. He is a member of the European Medical Writers’ Association (EMWA), having served on the Executive Committee and now being a member of the Education and Professional Development Committee. Dr Carpenter was a member of the group that in 2005 developed the EMWA guidelines on the role of medical writers in developing peer-reviewed publications. He has written chapters on pharmacology in several text books and is co-author of A Dictionary of Pharmacology and Allied Topics. For many years Dr Carpenter has been developing and delivering training workshops for the pharmaceutical industry and medical professionals. Topics include such topics as pharmacology, pharmacokinetics, making and delivering slide presentations, and medical writing.
Mgr Justyna Stefaniak - absolwentka matematyki (Wydział Matematyki, Fizyki i Informatyki Uniwersytetu Jagiellońskiego w Krakowie, 1998-2003), słuchaczka studiów doktoranckich (jw. w latach 2003-2007). Dotychczasowe doświadczenie zawodowe zdobyła pracując w: Katedrze Epidemiologii i Medycyny Zapobiegawczej Collegium Medicum UJ w Krakowie (2005-2008), Instytucie Arcana w Krakowie (2008-2009), Krakow Cardiovascular Research Institute (2009-2010), na stanowiskach matematyk i statystyk. Od 2009 właścicielka firmy DMSA (Data Management and Statistical Analysis). Współpracowała z Polską Akademią Nauk - Wydział Nauk o Ziemi (2005-2007) jako konsultant statystyczny. Prowadziła zajęcia z matematyki na Wydziale Biologii i Nauk o Ziemi oraz szkolenia z zaawansowanych metod analiz statystycznych oraz programu SAS (2004-2005). Członek Polskiej Grupy Narodowej Międzynarodowego Towarzystwa Biostatystyki Klinicznej. Brała udział w wielu szkoleniach z zakresu metod analiz statystycznych, uczestniczyła w konferencjach naukowych prezentując wyniki projektów w których brała udział. Jest współautorką 4 prac naukowych indeksowanych w Medline/Pubmed. Jej dodatkową pasją poza pracą jest zwiedzanie świata na rowerze.
Maciej Banach, MD, PhD, FESC, FASA,
Prof. nadzw. dr hab. med. Maciej Banach – Kierownik Zakładu Nadciśnienia Tętniczego, Katedry Nefrologii i Nadciśnienia Tętniczego Uniwersytetu Medycznego w Łodzi i Przewodniczący Oddziału Łódzkiego Polskiego Towarzystwa Nadciśnienia Tętniczego (PTNT). Autor ponad 250 publikacji z dziedziny kardiologii, hipertensjologii, lipidologii, kardiochirurgii i nefrologii za łączny impact factor 220.192 (tylko za prace w pełnej wersji), autor i współautor 14 książek (54 rozdziałów). Redaktor Naczelny Archives of Medical Science (AMS) (IF=1.012) oraz Cardiovascular Continuum, z-pca Redaktora Naczelnego w Clinical and Experimental Medical Letters (CEML) oraz Thyroid Research, redaktor 8 innych czasopism i członek Rady Naukowej 19 czasopism recenzowanych, w tym Angiology, Current Drug Therapy, Medical Science Monitor oraz Expert Opinion on Pharmacotherapy. Recenzent ponad 50 czasopism o charakterze międzynarodowym, w tym Journal of American College of Cardiology, Heart Rhythm, Journal of Human Hypertension, Heart czy American Journal of Cardiology. Członek Rady Młodych Naukowców oraz Komisji ds. Oceny Parametrycznej Czasopism Naukowych przy Minister Nauki i Szkolnictwa Wyższego. Członek World Association of Medical Editors, wielu innych międzynarodowych towarzystw naukowych oraz członek honorowy (fellow) European Society of Cardiology (FESC), American Society of Angiology (FASA) oraz Society of Geriatric Cardiology (FSGC; 2008-2010). Główne zainteresowania: hipertensjologia, lipidologia, farmakologia kliniczna.
Maria Koltowska-Haggstrom, MD, PhD
Maria Koltowska-Häggström, MD, PhD is Medical Director at KIGS/KIMS/ACROSTUDY Medical Outcomes, Pfizer Endocrine Care in Sollentuna, Sweden. Since 2001, Maria has been responsible for two large observational surveillance studies - KIMS® and ACROSTUDY®, containing data on more than 14 000 and almost 1000 patients, respectively. Maria is a leading member of numerous research groups investigating growth hormone disorders in adult patients managed in the real-life clinical setting. This has given her the unique opportunity, not only to study pituitary disorders in large cohorts of patients, but also to develop the skills associated with utilizing large databases for scientific work, in particular the complex data analyses required. She has also gained a wide experience in different ways of data presentations i.e. oral and poster presentations as well as publications. Her 28 peer-reviewed papers were published in the Journal of Clinical Endocrinology and Metabolism, European Journal of Endocrinology, Clinical Endocrinology, Growth Hormone and IGF Research, Hormone Research, Value in Health, Pharmacoepidemiology and Drug Safety, Polish Journal of Endocrinology and Management Issues (Warsaw University). She is a member of the Endocrine Society, the European Society of Endocrinology, the International Society for Pharmacoeconomics and Outcomes Research and the International Society for Quality of Life Research.
Dr Nicholas Wilkes is a consultant anaesthetist at Oxford Radcliffe Hospitals in the United Kingdom. His special interests cover the perioperative management of major surgical procedures such as transplant surgery and gynaecological oncology. He was trained as a doctor in Germany obtaining his MD from Hamburg University. For his anaesthetic training he joined the Royal Free Hospital and University College London in the UK. Dr Nicholas Wilkes became a specialist and a Fellow of the Royal College of Anaesthetists (FRCA) in 1997. After completion of his postgraduate training he spent some time in a dedicated research post. Dr Nicholas Wilkes presented the findings of my group at conferences in Cambridge, Amsterdam, Bergen, Barcelona, San Francisco, Buenos Aires, Oxford, and London. He is an occasional reviewer for Clinical Science. He was appointed as a consultant anaesthetist at Oxford in 2002. He is a secretary to the Nuffield Department of Anaesthetics Consultant Committee. After his appointment he founded the Oxford Transplant Group which he is still in charge of. This group provides anaesthetic services for kidney transplants, kidney-pancreas transplants, intestinal transplants, and multivisceral transplants.
When the post marketing surveillance data base KIGS was initiated 1987 he was the clinical lead. The work with KIGS gave him numerous opportunities to present data at international meetings. He built a big network in the pediatric endocrinology field. He became medical director of KIGS and the second post surveillance database including data from adults with growth hormone deficiencies, KIMS, 2000. This increased his network to include also endocrinologists.Patrick Wilton graduated from Karolinska Institute and worked as a pediatrician in Stockholm for 15 years. Spent one year as a Clinical Fellow in Neonatology at Vanderbilt University, Nashville,TN,USA. His dissertation for PhD covered compensatory renal hypertrophy, 1979. He joined the Swedish pharmaceutical company KabiVitrum 1985 and became in charge of the clinical trials of the newly developed recombinant human growth hormone, Genotropin. He later was involved in clinical trials of IGF-I in growth hormone receptor deficient children (Laron syndrome). When Pfizer Inc acquired Pharmacia he was offered to lead Medical Outcomes from Pfizer’s headquarters in New York, USA. During all the years in the pharmaceutical industry he has continued to present Posters and give oral presentations. He is a member of European Society Pediatric Endocrinology, Endocrine Society.
Professor Shalet is an honorary Consultant and Professor of Medicine and Endocrinology at the University of Manchester, UK. He completed a BSc in Physiology at London University and qualified in medicine at the Royal London Hospital. Medical training posts in London and Bristol were followed by an appointment at the Christie Hospital, Manchester, as Research Fellow in Endocrinology in 1974 and then subsequently Consultant in 1978. Professor Shalet has extensive research interests in the late endocrine effects following treatment of cancer, pituitary disorders and in particular abnormalities of growth hormone secretion. Previous positions and official activities include Chairman of the Strategic Planning Committee of the European Society of Pediatric Endocrinology, Co-Editor of the first edition of the Oxford Textbook of Endocrinology and a member of the Council of the Society for Endocrinology and the SAC in Endocrinology and Diabetes. Professor Shalet has served as President of the Endocrine Section of the Royal Society of Medicine, as a member of the Council of the European Society of Paediatric Endocrinology, was Chairman of the Specialist Training Committee in Diabetes and Endocrinology for the North West Region and as a member of the Clinical Practice Committee of the Society for Endocrinology.
Dr n. med. Zbigniew Siudak - lekarz, absolwent Wydziału Lekarskiego Collegium Medicum UJ w Krakowie (2004). Obecnie pracuje w II Klinice Kardiologii Szpitala Uniwersyteckiego w Krakowie. Autor i współautor ponad 30 artykułów naukowych, w tym większość w czasopismach z listy filadelfijskiej, kilkudziesięciu doniesień zjazdowych oraz dodatkowo rozdziałów w książkach polsko- i anglojęzycznych z zakresu kardiologii inwazyjnej oraz ostrych zespołów wieńcowych. Uczestnik i prezentujący wyniki swoich badań na konferencjach kardiologicznych w Europie i USA. W roku 2008 przebywał na stażu w Szpitalu Uniwersyteckim w Linköping w Szwecji. Członek Scientific Programme Committee EAPCI w kadencji 2009-2011 (European Association of Percutaneous Cardiovascular Interventions) oraz członek International Society of Clinical Biostatistics. Wykładowca akademicki. Opiekun studenckiego koła naukowego od 2004 roku. Redaktor naczelny portalu edukacyjnego www.cardio.pl. Laureat nagrody naukowej Wydziału Lekarskiego Polskiej Akademii Nauk w 2009 roku. Jego zainteresowania pozamedyczne obejmują astronomię i astrofizykę.
